Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion Inc Cl A (NY: ENFN )

9.380 +0.080 (+0.86%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enfusion Inc Cl A

< Previous 1 2 3 4 Next >
Enfusion Announces Appointment of Chief Operating Officer
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Third Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of Third Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Earnings Preview: Enfusion
Via Benzinga
Why Enfusion (ENFN) Stock Is Exploding Higher
Enfusion Inc (NYSE: ENFN) shares are trading higher by 20% to $11.06 Monday afternoon following a report suggesting the company is attracting takeover interest. What Else? 
Via Benzinga
What 4 Analyst Ratings Have To Say About Enfusion
Via Benzinga
Analyst Ratings for Enfusion
Via Benzinga
Why Enfusion Stock Surged Today
The company is growing profitably -- unusual for a small software company. 
Via The Motley Fool
Enfusion Launches Portfolio Workbench, Empowering Portfolio Managers to Seamlessly Rebalance Multi-Asset Portfolios
From Enfusion, Inc.
Via Business Wire
The 3 Most Undervalued Under-$10 Stocks to Buy in September 2023
Undervalued stocks are not just found in older industries; rather, many can be found in emerging spaces as well. 
Via InvestorPlace
Enfusion Announces Closing of New $100 Million Credit Facility
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Second Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion's Earnings: A Preview
Via Benzinga
Looking Into Enfusion's Return On Capital Employed
Via Benzinga
Enfusion Announces Date of Second Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
12 Information Technology Stocks Moving In Monday's Intraday Session
Via Benzinga
Enfusion To Present at the 43rd Annual William Blair Growth Stock Conference
From Enfusion, Inc.
Via Business Wire
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Enfusion Announces First Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Date of First Quarter 2023 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Announces Partnership With Leading Risk Management Provider Qontigo
From Enfusion, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
Via Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Enfusion Announces Fourth Quarter 2022 Results and Full Year 2022 Results
From Enfusion, Inc.
Via Business Wire
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga
Enfusion Announces Date of Fourth Quarter and Full Year 2022 Results
From Enfusion, Inc.
Via Business Wire
Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
From Enfusion, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
Via Benzinga
Enfusion Names Oleg Movchan as Chief Executive Officer
From Enfusion, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.